Moderna to Present at Chardan's Virtual 5th Annual Genetic Medicines ConferenceBusiness Wire • 09/28/21
Moderna CEO Predicts Pandemic Could End in 2022: Here's Why the Stock Could Plunge If He's RightThe Motley Fool • 09/28/21
Moderna Announces Supply Agreement with Peru for 20 Million Doses of Its COVID-19 VaccineBusiness Wire • 09/24/21
Whether the FDA approves a COVID-19 booster shot or not, Pfizer and Moderna have already made their moneyMarket Watch • 09/22/21
Moderna's COVID Vaccine Could Be Better Than Pfizer's -- Here's Why Its Stock Isn'tThe Motley Fool • 09/22/21
Moderna COVID-19 Vaccine Clinical Trial for People With Organ Transplant Starts at Feinstein InstitutesBusiness Wire • 09/21/21